RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼
What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and tolerability of an oral drug candidate, L-130 (a molecular modification of naturally occurring psilocin) and measure absolute pharmacokinetics of this new chemical entity (NCE) given alone and in conjunction with NAC. Following the successful completion of the first-in-man safety trials, a Phase Ib/IIa study will be implemented in healthy volunteers and patients"